Log in to save to my catalogue

Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome rel...

Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome rel...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8248392b8ab649598821f23895d2eb40

Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release

About this item

Full title

Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release

Publisher

England: BioMed Central Ltd

Journal title

Skeletal muscle, 2021-07, Vol.11 (1), p.17-17, Article 17

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Cancer cachexia (CAC) reduces patient survival and quality of life. Developments of efficient therapeutic strategies are required for the CAC treatments. This long-term process could be shortened by the drug-repositioning approach which exploits old drugs approved for non-cachexia disease. Amiloride, a diuretic drug, is clinically used for treatmen...

Alternative Titles

Full title

Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8248392b8ab649598821f23895d2eb40

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8248392b8ab649598821f23895d2eb40

Other Identifiers

ISSN

2044-5040

E-ISSN

2044-5040

DOI

10.1186/s13395-021-00274-5

How to access this item